SEC Form 4 insider trading filings tracked in real time from EDGAR

Dyne Therapeutics, Inc. (DYN) — Insider Trading

Insider trading activity for Dyne Therapeutics, Inc. sourced from SEC EDGAR Form 4 filings.

Overview

  • Total insider trades: 6
  • Last trade date: Aug 17, 2026
  • Ticker: DYN

Top Insiders

  • Rhodes Jason P — 2 trades, buy: $0, sell: $41.0M
  • Cox John (CEO & President) — 1 trades, buy: $0, sell: $131K
  • Lucera Erick (Chief Financial Officer) — 1 trades, buy: $0, sell: $47K
  • Kerr Douglas (Chief Medical Officer) — 1 trades, buy: $0, sell: $41K
  • Friedl-Naderer Johanna (Chief Commercial Officer) — 1 trades, buy: $0, sell: $6K

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Aug 13, 2026 Cox John DYN Dyne Therapeutics, Inc. SELL 4,986 $131K
Aug 14, 2026 Rhodes Jason P DYN Dyne Therapeutics, Inc. SELL 1,359,674 $34.0M
Aug 13, 2026 Rhodes Jason P DYN Dyne Therapeutics, Inc. SELL 268,354 $7.0M
Aug 13, 2026 Lucera Erick DYN Dyne Therapeutics, Inc. SELL 1,797 $47K
Aug 13, 2026 Kerr Douglas DYN Dyne Therapeutics, Inc. SELL 1,556 $41K
Aug 13, 2026 Friedl-Naderer Johanna DYN Dyne Therapeutics, Inc. SELL 226 $6K

← All companies · Full trades feed